HIF-1 has been associated with radioresistance in cancer cells by activating several downstream effectors involved in different pathways linked to the repair of IR-induced damages, suppression of anti-apoptotic factors, and enhancement in the aggressiveness of cancer cells. This evidence concerns the gene SETD2 and cancer.